- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Cystic Fibrosis Related Diabetes in Japan
Total 500 results
-
Gilead SciencesCompletedDiabetic Kidney DiseaseUnited States, Japan, New Zealand, Australia, Canada
-
Yokohama City University Medical CenterCompletedDiabetes Mellitus | Renal Failure | Essential Hypertension | Chronic NephropathyJapan
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Japan
-
COLM Study Research OrganizationJapan Heart FoundationCompletedHypertension | Cardiovascular Disease | DiabetesJapan
-
BayerCompletedDiabetic RetinopathyKorea, Republic of, Russian Federation, Hong Kong, Taiwan, United States, Argentina, Japan, Denmark, Israel, Spain, Sweden, China, Colombia, Italy, Portugal
-
Eli Lilly and CompanyAlkermes, Inc.Completed
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusJapan
-
Novartis PharmaceuticalsCompleted
-
Boehringer IngelheimCompletedDiabetic NephropathiesJapan
-
Nagoya UniversityUnknownHypertension | Healthy | Diabetes Mellitus | Hyperlipidemia | Metabolic Syndrome XJapan
-
Aichi Gakuin UniversityUnknownCoronary Artery Disease | Diabetes Mellitus | Impaired Glucose ToleranceJapan
-
University of the RyukyusCompletedCoronary Artery Disease | Inflammation | Diabetes Mellitus, Type 2 | Diarrhea | Colchicine | White Blood CellJapan
-
Shiga UniversityUnknownHypertension | Diabetes Mellitus | AlbuminuriaJapan
-
Novartis PharmaceuticalsActive, not recruitingProliferative Diabetic RetinopathyChina, India, Japan, Russian Federation, Turkey, Canada, United States, Australia, Korea, Republic of, Brazil, Philippines, Puerto Rico, Taiwan, Argentina, Chile, Mexico
-
Kyorin UniversityCompletedDisease Progression | Autosomal Dominant Polycystic Kidney DiseaseJapan
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Poland, United States, Japan, Korea, Republic of, Germany, Bulgaria, South Africa, Portugal, Ukraine
-
BayerActive, not recruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseJapan, Spain, Netherlands, Denmark, United States
-
SanofiCompletedType 2 Diabetes MellitusJapan
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Romania, Russian Federation, Germany, Netherlands, Turkey, Bulgaria, India, Taiwan, Czech Republic, Tunisia, Japan, Egypt, Israel, Korea, Republic of, Thailand
-
Institute for Clinical Effectiveness, JapanCompletedCoronary Disease | Diabetes Mellitus | Dipeptidyl-Peptidase 4 Inhibitors | LDL Cholesterol | Glycosylated HemoglobinJapan
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan, Korea, Republic of, China, Turkey
-
TakedaCompleted
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, Japan, Serbia, South Africa, China, Slovakia
-
BayerCompletedDiabetic Kidney DiseaseBelgium, Finland, France, Spain, China, Hong Kong, Switzerland, United States, Colombia, Turkey, Greece, New Zealand, Poland, Korea, Republic of, Portugal, Taiwan, Japan, Russian Federation, Singapore, Australia, Netherlands, Sweden, Austr... and more
-
SanofiCompletedType 2 Diabetes MellitusJapan
-
GlaxoSmithKlineRecruitingPainUnited States, Germany, Japan, Spain, Canada, China, United Kingdom, South Africa, Korea, Republic of, France, Poland, Turkey
-
TakedaCompleted
-
SanofiCompletedType 2 Diabetes MellitusJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1United States, India, Italy, Russian Federation, United Kingdom, Canada, Netherlands, Austria, Japan, Spain, Germany, Turkey
-
Eli Lilly and CompanyActive, not recruiting
-
AstraZenecaCompletedDiabetes Mellitus Type 2United States, Australia, Canada, Denmark, Finland, Germany, Israel, Italy, Japan, Korea, Republic of, Norway, Portugal, Singapore, Spain, Sweden, Taiwan, United Kingdom
-
PfizerTerminatedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Japan
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan, Taiwan, Korea, Republic of
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedDiabetes Mellitus, Type 2 | Diabetic NephropathyUnited States, Canada, France, Germany, Poland, Ukraine, United Kingdom, China, Taiwan, Spain, Argentina, Colombia, Mexico, Bulgaria, India, Malaysia, Romania, Serbia, South Africa, Japan, Australia, Korea, Republic of, Chile, New Zealand and more
-
Eli Lilly and CompanyCompleted
-
Novo Nordisk A/SCompleted
-
AstraZenecaBristol-Myers SquibbCompletedType2 Diabetes | High Blood SugarJapan
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Japan
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
AstraZenecaCompletedType 2 Diabetes MellitusJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Otsuka Pharmaceutical Co., Ltd.RecruitingAntidiuretic Hormone, Inappropriate SecretionJapan
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Japan
-
AstraZenecaCompletedType 2 Diabetes MellitusJapan